These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. High-resolution epitope mapping by HX MS reveals the pathogenic mechanism and a possible therapy for autoimmune TTP syndrome. Casina VC; Hu W; Mao JH; Lu RN; Hanby HA; Pickens B; Kan ZY; Lim WK; Mayne L; Ostertag EM; Kacir S; Siegel DL; Englander SW; Zheng XL Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9620-5. PubMed ID: 26203127 [TBL] [Abstract][Full Text] [Related]
44. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. Tsai HM; Lian EC N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246 [TBL] [Abstract][Full Text] [Related]
45. Immunogenic hotspots in the spacer domain of ADAMTS13 in immune-mediated thrombotic thrombocytopenic purpura. Velásquez Pereira LC; Roose E; Graça NAG; Sinkovits G; Kangro K; Joly BS; Tellier E; Kaplanski G; Falter T; Von Auer C; Rossmann H; Feys HB; Reti M; Prohászka Z; Lämmle B; Voorberg J; Coppo P; Veyradier A; De Meyer SF; Männik A; Vanhoorelbeke K J Thromb Haemost; 2021 Feb; 19(2):478-488. PubMed ID: 33171004 [TBL] [Abstract][Full Text] [Related]
46. Thrombotic thrombocytopenic purpura with an autoantibody to ADAMTS13 complicating Sjögren's syndrome: two cases and a literature review. Yamashita H; Takahashi Y; Kaneko H; Kano T; Mimori A Mod Rheumatol; 2013 Mar; 23(2):365-73. PubMed ID: 22526830 [TBL] [Abstract][Full Text] [Related]
47. The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura. Starke R; Machin S; Scully M; Purdy G; Mackie I Br J Haematol; 2007 Feb; 136(4):649-55. PubMed ID: 17367414 [TBL] [Abstract][Full Text] [Related]
48. Interferon-α is not elevated in idiopathic thrombotic thrombocytopenic purpura patients. Watanaboonyongcharoen P; Whinna HC; Park YA J Clin Apher; 2014 Dec; 29(6):336-8. PubMed ID: 24764259 [TBL] [Abstract][Full Text] [Related]
49. Inverse correlation of free and immune complex-sequestered anti-ADAMTS13 antibodies in a patient with acquired thrombotic thrombocytopenic purpura. Ferrari S; Knöbl P; Kolovratova V; Plaimauer B; Turecek PL; Varadi K; Rottensteiner H; Scheiflinger F J Thromb Haemost; 2012 Jan; 10(1):156-8. PubMed ID: 22044668 [No Abstract] [Full Text] [Related]
50. Rituximab as preventive therapy of a clinical relapse in TTP with ADAMTS13 inhibitor. Schleinitz N; Ebbo M; Mazodier K; Poullin P; Bernit E; Veit V; Veyradier A; Fakhouri F; Kaplanski G; Harle JR Am J Hematol; 2007 May; 82(5):417-8. PubMed ID: 17266057 [No Abstract] [Full Text] [Related]
51. Neutralization of inhibitory antibodies and restoration of therapeutic ADAMTS-13 activity levels in inhibitor-treated rats by the use of defined doses of recombinant ADAMTS-13. Plaimauer B; Schiviz A; Kaufmann S; Höllriegl W; Rottensteiner H; Scheiflinger F J Thromb Haemost; 2015 Nov; 13(11):2053-62. PubMed ID: 26340698 [TBL] [Abstract][Full Text] [Related]
52. ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura. Zheng XL Annu Rev Med; 2015; 66():211-25. PubMed ID: 25587650 [TBL] [Abstract][Full Text] [Related]
53. [Recent progress of diagnosis and treatment for immune-mediated hematological diseases. Topics: III. Diagnosis and treatment; 4. Thrombotic thrombocytopenic purpura]. Matsumoto M Nihon Naika Gakkai Zasshi; 2014 Jul; 103(7):1613-21. PubMed ID: 25154256 [No Abstract] [Full Text] [Related]
54. ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura. Bettoni G; Palla R; Valsecchi C; Consonni D; Lotta LA; Trisolini SM; Mancini I; Musallam KM; Rosendaal FR; Peyvandi F J Thromb Haemost; 2012 Aug; 10(8):1556-65. PubMed ID: 22672482 [TBL] [Abstract][Full Text] [Related]
55. Administration of immunoglobulin G-degrading enzyme of Streptococcus pyogenes (IdeS) for persistent anti-ADAMTS13 antibodies in patients with thrombotic thrombocytopenic purpura in clinical remission. Stubbs MJ; Thomas M; Vendramin C; Sonesson E; Kjellman C; Järnum S; Stenberg Y; Elfving C; Scully M Br J Haematol; 2019 Jul; 186(1):137-140. PubMed ID: 30488420 [No Abstract] [Full Text] [Related]
56. Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Froehlich-Zahnd R; George JN; Vesely SK; Terrell DR; Aboulfatova K; Dong JF; Luken BM; Voorberg J; Budde U; Sulzer I; Lämmle B; Kremer Hovinga JA Haematologica; 2012 Feb; 97(2):297-303. PubMed ID: 21993669 [TBL] [Abstract][Full Text] [Related]